The fragile X mental retardation protein inhibits translation via interacting with mRNA

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Fragile X syndrome, a common inherited intellectual disability, is caused by the loss of function of the fragile X mental retardation protein (FMRP).
• The precise function of FMRP and how its absence leads to cognitive impairments remain unclear.
• Emerging evidence suggests FMRP, an RNA-binding protein found on polyribosomes, may play a role in regulating protein translation.

Purpose of the Study:

• To investigate the role of FMRP in translational regulation.
• To determine the mechanism by which FMRP influences protein synthesis.
• To elucidate how FMRP's function or dysfunction contributes to Fragile X syndrome.

Main Methods:

• In vitro translation assays using rabbit reticulocyte lysate.
• Purified recombinant FMRP was used to assess its effect on brain poly(A) RNA translation.
• Experiments involved assessing mRNA degradation, FMRP-mRNA interactions, and the influence of FMRP-binding sites on translation.

Main Results:

• Recombinant FMRP demonstrated dose-dependent inhibition of brain poly(A) RNA translation without causing mRNA degradation.
• FMRP's inhibitory effect was enhanced by pre-incubation with mRNA and reversed by the 3'-untranslated region of the Fmr1 message.
• FMRP specifically suppressed the translation of FMRP-binding transcripts (e.g., parathyroid hormone) but not non-binding transcripts (e.g., beta-globin).
• Deletion of the FMRP-binding site abolished the inhibitory effect, confirming the necessity of direct interaction.

Conclusions:

• FMRP functions as a selective inhibitor of protein translation.
• FMRP exerts its inhibitory effect through direct binding to specific messenger RNA targets.
• These findings provide a molecular mechanism linking FMRP loss to cognitive deficits in Fragile X syndrome.